Iwasaki, Roman S.
Ozdilek, Bagdeser A.
Garst, Andrew D.
Choudhury, Alaksh
Batey, Robert T. http://orcid.org/0000-0002-1384-6625
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (GM073850)
Article History
Received: 20 February 2019
Accepted: 24 February 2020
First Online: 13 March 2020
Competing interests
: The authors R.T.B., R.S.I., and A.D.G. declare the following competing financial interests: R.T.B., R.S.I., and A.D.G. have submitted a patent application (No. PCT/US2020/013718) related to the use of agRNA for gene editing. A.D.G. has competing financial interests in Inscripta Inc., a company that is commercializing multiplexed genome editing platforms. The authors B.A.O. and A.C. declare no competing interests.